Références
[1]AgerEI,NeoJ,ChristophiC.Thereninangiotensinsystemandmalignancy.
Carcinogenesis.2008;29:167584.
[2]KhakooAY,SidmanRL,PasqualiniR,ArapW.Doesthereninangiotensinsystem
participateinregulationofhumanvasculogenesisandangiogenesis?.CancerRes.
2008;68:91125.
[3]TamaratR,SilvestreJS,DuriezM,LevyBI.AngiotensinIIangiogeniceffectinvivo
involvesvascularendothelialgrowthfactorandinflammationrelatedpathways.LabInvest.
2002;82:74756.
[4]SilvestreJS,TamaratR,SensbonmatsuT,etal.AntiangiogeniceffectofangiotensinII
type2receptorinischemiainducedangiogenesisinmicehindlimb.CircRes.
2002;90:10729.
[5]LeverAF,HoleDJ,GillisCR,etal.DoinhibitorsofangiotensinIconvertingenzyme
protectagainstriskofcancer?.Lancet.1998;352:17984.
[6]HuangW,WuYL,ZhongJ,JiangFX,TianXL,YuLF.AngiotensinIItype1receptor
antagonistsuppressangiogenesisandgrowthofgastriccancerxenografts.DigDisSci.
2008;53:120610.
[7]KosugiM,MiyajimaA,KikuchiE,etal.AngiotensinIItype1receptorantagonist
enhancescisdichlorodiammineplatinuminducedcytotoxicityinmousexenograftmodelof
bladdercancer.Urology.2009;73:65560.
[8]NoguchiR,YoshijiH,IkenakaY,etal.Synergisticinhibitoryeffectofgemcitabineand
angiotensintype1receptorblocker,losartan,onmurinepancreatictumorgrowthviaanti
angiogenicactivities.OncolRep.2009;22:35560.
[9]NakaiY,IsayamaH,IjichiH,etal.Inhibitionofreninangiotensinsystemaffects
prognosisofadvancedpancreaticcancerreceivinggemcitabine.BrJCancer.
2010;103:16448.
[10]LeverAF,HoleDJ,GillisCR,etal.DoinhibitorsofangiotensinIconvertingenzyme
protectagainstriskofcancer?.Lancet.1998;352:17984.
[11]FujimotoY,SasakiT,TsuchidaA,ChayamaK.AngiotensinIItype1receptor
expressioninhumanpancreaticcancerandgrowthinhibitionbyangiotensinIItype1
receptorantagonist.FEBSLett.2001;495:197200.
[12]ArafatHA,GongQ,ChipitsynaG,RizviA,SaaCT,YeoCJ.Antihypertensivesasnovel
antineoplastics:angiotensinIconvertingenzymeinhibitorsandangiotensinIItype1
receptorblockersinpancreaticductaladenocarcinoma.JAmCollSurg.2007;204:996
1006.
[13]FendrichV,ChenNM,NeefM,etal.TheangiotensinIconvertingenzymeinhibitor
enalaprilandaspirindelayprogressionofpancreaticintraepithelialneoplasiaandcancer
formationinageneticallyengineeredmousemodelofpancreaticcancer.Gut.2010;59:630
7.
[14]GongQ,DavisM,ChipitsynaG,YeoCJ,ArafatHA.BlockingangiotensinIItype1
receptortriggersapoptoticcelldeathinhumanpancreaticcancercells.Pancreas.
2010;39:58194.
[15]YanaseK,YoshijiH,IkenakaY,etal.Synergisticinhibitionofhepatocellularcarcinoma
growthandhepatocarcinogenesisbycombinationof5fluorouracilandangiotensin
convertingenzymeinhibitorviaantiangiogenicactivities.OncolRep.2007;17:4416.